Browsing by Sponsor/Funder Dr. Heinz-Horst Deichmann Stiftung

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 27  next >
Issue DateTitleAuthor(s)
Dec-201968Ga-DOTATATE PET/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumoursSharma, R; Wang, WM; Yusuf, S; Evans, J; Ramaswami, R, et al
19-Mar-2021A combination of surgery, theranostics, and liquid biopsy - a personalised oncologic approach to treatment of patients with advanced metastatic neuroendocrine neoplasmsFrilling, A; Clift, AK; Frampton, AE; Bomanji, J; Kaemmerer, D, et al
31-Aug-2016A Delphic Consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumour disease managementOberg, KE; Krenning, E; Sundin, A; Bodei, L; Kidd, M, et al
Nov-2021A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility.Modlin, IM; Kidd, M; Falconi, M; Filosso, PL; Frilling, A, et al
18-Jun-2018A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.Alvarez, MJ; Subramaniam, PS; Tang, LH; Grunn, A; Aburi, M, et al
1-Jul-2021Circulating microRNAs in small-bowel neuroendocrine tumors: a potential tool for diagnosis and assessment of effectiveness of surgical resectionMalczewska, A; Frampton, AE; Mato Prado, M; Ameri, S; Dabrowska, AF, et al
18-May-2021Early identification of residual disease after neuroendocrine tumor resection using a liquid biopsy multigenomic mRNA signature (NETest)Modlin, IM; Kidd, M; Oberg, K; Falconi, M; Filosso, PL, et al
6-Jul-2016Functional imaging in liver tumoursRonot, M; Kieran Clift, A; Vilgrain, V; Frilling, A; , et al
15-Jan-2018Goblet cell carcinomas of the appendix: rare but aggressive neoplasms with challenging management.Clift, AK; Kornasiewicz, O; Drymousis, P; Faiz, O; Wasan, H, et al
28-May-2018Liver transplantation and multivisceral transplantation in the management of patients with advanced neuroendocrine tumoursClift, A; Frilling, A;
16-Jan-2018MAFA missense mutation causes familial insulinomatosis and diabetes mellitus.Iacovazzo, D; Flanagan, SE; Walker, E; Quezado, R; De Sousa Barros, FA, et al
Sep-2021Molecular genomic assessment using a blood-based mRNA signature (NETest) is cost effective and predicts neuroendocrine tumor recurrence with 94% accuracy.Modlin, IM; Kidd, M; Frilling, A; Falconi, M; Filosso, PL, et al
1-Jun-2021Multifocal neuroendocrine tumour of the small bowel presenting as an incarcerated incisional hernia: a surgical challenge in a high-risk patientSteinkraus, K; Andresen, JR; Clift, AK; Liedke, MO; Frilling, A, et al
25-Aug-2017Neoadjuvant peptide receptor radionuclide therapy and modified multivisceral transplantation for an advanced small intestinal neuroendocrine neoplasm: an updated case reportClift, AK; Giele, H; Reddy, S; Macedo, R; Al-Nahhas, A, et al
27-Sep-2019Neuroendocrine neoplasms of the small bowel and pancreasClift, AK; Kidd, M; Bodei, L; Toumpanakis, C; Baum, RP, et al
30-Jan-2019Observational study to assess quality of life in patients with pancreatic neuroendocrine tumours receiving treatment with Everolimus: The OBLIQUE Study (UK Phase IV trial)Ramage, JK; Punia, P; Faluyi, O; Frilling, A; Meyer, T, et al
1-Feb-2019Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort studyCarlsen, EA; Fazio, N; Granberg, D; Grozinsky-Glasberg, S; Ahmadzadehfar, H, et al
16-Aug-2017Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors.Frilling, A; Clift, AC;
1-Jul-2019Radioembolisation with 90Y microspheres for neuroendocrine liver metastases: an institutional case series, systematic review and meta-analysisFrilling, A; Clift, AK; Braat, AJAT; Alsafi, A; Wasan, HS, et al
23-Oct-2019Radioembolization with Y-90 resin microspheres of neuroendocrine liver metastases after initial peptide receptor radionuclide therapyBraat, AJAT; Ahmadzadehfar, H; Kappadath, SC; Stothers, CL; Frilling, A, et al